4//SEC Filing
Autor Deborah M. 4
Accession 0001628280-24-049149
CIK 0001723128other
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 4:26 PM ET
Size
6.9 KB
Accession
0001628280-24-049149
Insider Transaction Report
Form 4
Autor Deborah M.
Director
Transactions
- Sale
Class A Common Stock
2024-11-21$8.41/sh−6,771$56,944→ 86,631 total - Sale
Class A Common Stock
2024-11-22$8.34/sh−33,229$277,130→ 53,402 total
Footnotes (2)
- [F1]The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.38 to $8.47 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.
- [F2]The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.30 per share to $8.41 per share, inclusive. The reporting person undertakes to provide Amneal Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001884671
Filing Metadata
- Form type
- 4
- Filed
- Nov 24, 7:00 PM ET
- Accepted
- Nov 25, 4:26 PM ET
- Size
- 6.9 KB